GNS Taps Nationally Regarded Epidemiologist to Put Discoveries From Causal Machine Learning and Simulation Platform in ‘Clinical Context’

Veteran Healthcare Leader Julie Slezak Appointed to Executive Vice President of Clinical Analytics CAMBRIDGE, Mass. – April 4, 2017 – Leading precision medicine company GNS Healthcare (GNS) today announced that nationally regarded epidemiologist and biostatistician Julie Slezak has been named to the newly created position Executive Vice President of Clinical Analytics. Slezak, who previously headed […]

Celgene Enters Into Service and License Arrangement for GNS Healthcare’s Causal Machine Learning Platform to Accelerate Value-Based and Precision Medicine Development

CAMBRIDGE, Mass. – November 29, 2016 – GNS Healthcare (GNS), a leading precision medicine company that applies causal machine learning technology to massive and diverse data streams to better match drugs and other health interventions to individual patients, today announced that Celgene Corporation has entered into a service and license arrangement for the rights to […]

Big Data Analytics Research Projects Target Cancer, Genomics

Several recently announced collaborations between academic research institutions and big data analytics vendors powering advanced discovery technologies will bring the power of big data to new studies that may have significant impacts on future therapies and treatments.  With oncology and genomics in the spotlight, personalized medicine is poised to take a leap forward as researchers […]

MobiHealthNews: GNS Healthcare raises $10M for precision medicine analytics

Cambridge, Massachusetts-based GNS Healthcare, which has developed an analytics tool for precision medicine and population health, raised $10 million from Celgene Corporation, Alexandria Real Estate Equities, and Gi Global Health Fund. Existing investors Cambia Health Solutions, Heritage Provider Network, and Mitsui USA, the US subsidiary of Japan’s Mitsui & Co, also participated. This brings the company’s total funding […]